Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Cipla Stays Upbeat On Advair Generic With ‘Superior’ Cost Position, Derisks Abraxane
Outlines Impact Of China Zero-COVID Policy
10 Nov 2022
•
By
Anju Ghangurde
New Revenue Base For Cipla's US business • Source: Shutterstock
More from Earnings
More from Business